Clinical Trials Logo

Filter by:
NCT ID: NCT05988554 Completed - Skin Condition Clinical Trials

Efficacy Testing of Hibiscus Sabdariffa Extract and Collagen Products

Start date: June 5, 2023
Phase: N/A
Study type: Interventional

To assess Hibiscus sabdariffa extract and collagen products on skin condition improvement

NCT ID: NCT05988502 Completed - Heart Failure Clinical Trials

Auricular Acupressure Relieves Constipation for Patients With Heart Failure in Hospital

Start date: March 6, 2022
Phase: N/A
Study type: Interventional

This study aimed to investigate the effect of auricular acupressure (AA) to relieve constipation symptoms and improve quality of life in patients hospitalized for their heart failure. A total of 72 participants were randomly assigned and 68 (33 in the AA group and 35 in the control group) completed the study. Outcomes were measured by the Bristolv Stool Form Scale, Constipation Assessment Scale, Patient Assessment of Constipation Symptoms, Visual Scale Analog, Beck Anxiety Inventory and Beck Depression Inventory at baseline, Weeks 1 and 2, as well as Constitution in Chinese Medicine Questionnaire and Patient Assessment of Constipation Quality of Life at baseline and Week 2.

NCT ID: NCT05987722 Completed - Periodontal Surgery Clinical Trials

Effectiveness of Enoxolone on Oral Conditions of Patients With Periodontal Surgery

Enoxolone
Start date: July 30, 2021
Phase: N/A
Study type: Interventional

Abstract Aim:The Enoxolone (18β-glycyrrhetinic acid; BGA) is a bioactive compound in licorice that exhibits potential anti-ulcer, anti-inflammatory, and anti-microbial activities, relieve oral ulcers, pain, improve gingivitis and dental plaque from past relevant experimental studies,but few clinical trials have evaluated its clinical effectiveness. Therefore, the purpose of this study is to evaluate the effectiveness of Enoxolone on oral conditions of patients with periodontal surgery. Methods:This study is a randomized controlled trial. Patients with severe chronic periodontitis who needed to accept periodontal surgery were randomly assigned to two groups, the experimental group was Enoxolone toothpaste, and the control group for Sensodyne toothpaste. After the operation, toothpaste was used three times a day to clean the mouth for 12 weeks . Clinical evaluation was using the patient-reported pain score, painkillers, wound healing index (complete epithelization and color matching score), periodontal pocket depth, gingiva index, plaque index and were recorded before operation and 1st, 2nd, 3rd, 4th, 8th, 12th week after surgery. Data set performs repeated-measures for the change in mean differences by using the two-tailed independent t tests and generalized linear model.

NCT ID: NCT05987046 Completed - Resistance Training Clinical Trials

Contrast Training, Post-activation Countermovement Jump Performance in High Strength Male

Start date: September 4, 2023
Phase: N/A
Study type: Interventional

The study investigated the effects of three contrast training sessions in a week on post-activation countermovement jump performance in high strength male.

NCT ID: NCT05983328 Completed - Clinical trials for Nonalcoholic Steatohepatitis

Phase I Pharmacokinetic Study of HUYPS-1 in Healthy Volunteers

Start date: May 10, 2016
Phase: Phase 1
Study type: Interventional

Fasting Period: At least 10 hours prior to dosing until 4 hours post-dose of each study period. Period: 24 hours post dose in each period. Each subject will complete two study periods. Washout Period: At least one week after dosing of the previous period. Confinement: From at least 10 hours prior to dosing until at least 12 hours post-dose, for a total of at least 22 hours for each study period.

NCT ID: NCT05978869 Completed - Clinical trials for Physical Activity Levels

Gamified Fitness Training to Promote Children's Physical Activity

Start date: February 14, 2018
Phase: N/A
Study type: Interventional

The study aimed to introduce gamified physical fitness training in health education with the goal of enhancing physical activity levels and assessing its feasibility within a small-scale context involving 11-12-year-old children.

NCT ID: NCT05975853 Completed - Sleep Quality Clinical Trials

Effects of Binaural Beat Music on Elderly Sleep

Start date: September 1, 2022
Phase: N/A
Study type: Interventional

Background: Older people in long-term care institutions often have poor sleep quality and depression, which may negatively affect their health and welfare. Binaural beat music (BBM) has been proposed as a possible intervention. However, its effects on older people with poor sleep quality in long-term care institutions is still unclear. Objective: This study aimed to examine the effects of binaural beat music on sleep quality, heart rate variability, and depression in older people with poor sleep quality in a long-term care institution Methods: A single-blind randomized controlled trial design was employed and 64 older participants with poor sleep quality were recruited from a long-term care institution in Taiwan. Participants were randomized into the BBM group or control (sham) group (32 per group) and received 14 days of intervention. During the intervention period, participants in the experimental group listened to 20 minutes of Taiwanese Hokkien oldies embedded with BBM once in the morning and afternoon thrice a week. Participants in the control group only listened to Taiwanese Hokkien oldies. Questionnaires and heart rate variability analysis were used to assess participants' sleep quality, heart rate variability, and depressive symptoms.

NCT ID: NCT05974397 Completed - Clinical trials for Acute Myocardial Infarction

Nationwide Trends in Incidence, Healthcare Utilization, and Mortality in Hospitalized Acute Myocardial Infarction Patients in Taiwan

Start date: September 30, 2021
Phase:
Study type: Observational

This was a retrospective study using the Taiwan's National Health Insurance Research Database (NHIRD). The study employed two study designs for different purposes as follows: - A cross-sectional analysis was conducted to explore the annual incidence trends. - A longitudinal cohort study was conducted to assess baseline characteristics, treatment patterns, long-term healthcare utilization, and cause-specific mortality among incident AMI patients. In each part, the study was conducted for AMI, and separately for ST-segment elevation and non-ST- segment elevation myocardial infarction (STEMI and NSTEMI)

NCT ID: NCT05974241 Completed - ADHD Clinical Trials

Irritability in Children With ADHD and Emotion Dysregulation

Start date: April 21, 2017
Phase: Phase 4
Study type: Interventional

Objective: Emotion dysregulation is common among children with ADHD and associated with a broad range of adult psychopathology, which is similar to the longitudinal outcomes of childhood irritability. However, the profiles of irritability in children with ADHD and emotion dysregulation has been understudied. This study aimed to investigate the efficacy of methylphenidate and aripiprazole in the treatment of irritability in children with ADHD and emotion dysregulation. In addition, the clinical profiles and neuropsychological characteristics of irritability in children with ADHD were explored.

NCT ID: NCT05972798 Completed - Clinical trials for Late Life Depression

Exploration of the Potential Mechanisms of n-3 Fatty Acids Supplementation in Depression and Cognitive Function in Patients With Late-life Depression

Start date: September 25, 2018
Phase: N/A
Study type: Interventional

Depression in the elderly causes considerable distress, disability, and loss of life. The accelerating aging boom is accentuating the importance of addressing late life depression (LLD). Extensive efforts in searching for effective and safety treatment yielded unsatisfactory results. Among the multiple agents in LLD treatment, long-chain polyunsaturated omega-3 fatty acids (omega-3 PUFA) stands out as an interesting compound as it addressed two main features in LLD, depressive mood and cognitive function. However, how it affects the brain remains unknown. Therefore, in an on-going double-blind randomized placebo-controlled study using 48 weeks omega-3 PUFA supplement in LLD treatment, we plan to perform two MRI scans (pre-treatment and post-treatment), in an effort to understand the unique neurobiology of omega-3 PUFA in the treatment of LLD. Along the trial, neuropsychological function and associated inflammatory markers were also collected.